Haemonetics Corp. (HAE)
108.39
-0.41
(-0.38%)
USD |
NYSE |
Aug 24, 16:00
108.39
0.00 (0.00%)
After-Hours: 20:00
Haemonetics Debt to Equity Ratio : 1.403 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.403 |
| March 31, 2026 | 1.601 |
| December 31, 2025 | 1.344 |
| September 30, 2025 | 1.442 |
| June 30, 2025 | 1.388 |
| March 31, 2025 | 1.564 |
| December 31, 2024 | 1.351 |
| September 30, 2024 | 1.394 |
| June 30, 2024 | 1.352 |
| March 31, 2024 | 0.9103 |
| December 31, 2023 | 0.9229 |
| September 30, 2023 | 0.8529 |
| June 30, 2023 | 0.8847 |
| March 31, 2023 | 0.945 |
| December 31, 2022 | 0.9881 |
| September 30, 2022 | 1.122 |
| June 30, 2022 | 0.9994 |
| March 31, 2022 | 1.116 |
| December 31, 2021 | 1.064 |
| September 30, 2021 | 1.118 |
| June 30, 2021 | 1.158 |
| March 31, 2021 | 1.064 |
| December 31, 2020 | 0.4308 |
| September 30, 2020 | 0.6947 |
| June 30, 2020 | 0.868 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.7525 |
| December 31, 2019 | 0.752 |
| September 30, 2019 | 0.668 |
| June 30, 2019 | 0.7725 |
| March 31, 2019 | 0.5242 |
| December 31, 2018 | 0.5346 |
| September 30, 2018 | 0.49 |
| June 30, 2018 | 0.5161 |
| March 31, 2018 | 0.3372 |
| December 31, 2017 | 0.3283 |
| September 30, 2017 | 0.3577 |
| June 30, 2017 | 0.3922 |
| March 31, 2017 | 0.4254 |
| December 31, 2016 | 0.4362 |
| September 30, 2016 | 0.518 |
| June 30, 2016 | 0.5586 |
| March 31, 2016 | 0.5654 |
| December 31, 2015 | 0.5936 |
| September 30, 2015 | 0.559 |
| June 30, 2015 | 0.5455 |
| March 31, 2015 | 0.518 |
| December 31, 2014 | 0.5142 |
| September 30, 2014 | 0.5238 |
| June 30, 2014 | 0.5287 |
| March 31, 2014 | 0.5224 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Boston Scientific Corp. | 0.5064 |
| Integra LifeSciences Holdings Corp. | 1.964 |
| Globus Medical, Inc. | 0.0235 |
| Abbott Laboratories | 0.638 |
| AngioDynamics, Inc. | 0.0641 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.365B |
| Total Liabilities (Quarterly) | 1.528B |
| Shareholders Equity (Quarterly) | 837.10M |
| Current Ratio | 3.080 |
| Net Debt Paydown Yield | 0.64% |